Health·3,543 stories
A Stanford-led study found that repairing the immune system's natural ability to clear senescent "zombie" cells — rather than killing them directly — reversed signs of frailty and cognitive decline in
UnitedHealth Group beat Q2 earnings expectations, lifting its stock roughly 3%, but executives' comments on Thursday's call signaled that more financial strain is coming for the employers and workers
A paralysed man retained hand movement and pressure sensation for months after brain stimulation was switched off, suggesting the implant prompted lasting neuroplastic rewiring rather than only tempor
Astronomers detected an atmosphere on LHS 1140b, a rocky, temperate exoplanet 50 light years from Earth — the first confirmed on a potentially habitable world. The helium signal appeared in 2024 but v
Roche's experimental Alzheimer's drug trontinemab clears brain amyloid while causing serious brain bleeds in under 5% of patients — compared with 20-40% for the approved antibody therapies lecanemab a
A man left quadriplegic by a 2020 diving accident regained the ability to move his arms and feel touch after receiving an experimental brain and spinal cord implant in 2023, allowing him to pet his do
UK vaccine advisers now recommend that teenagers around age 15 receive a free MenB jab, reversing earlier advice after the country's largest outbreak of the disease killed two people earlier this year
UnitedHealth Group posted quarterly results well above Wall Street expectations and substantially raised its full-year earnings projection, sending shares up 6% in premarket trading as investors gaine
Prediction market exchange Kalshi announced Thursday it will begin taking bets on clinical trials and FDA regulatory approvals through a partnership with clinical trial outcomes firm AppliedXL.
Eli Lilly announced Thursday it will acquire AtaiBeckley, a psychedelics-focused biotech developing mental health treatments, for $2.8 billion in cash plus up to $1 billion in milestone payments.
Amylyx Pharmaceuticals is approaching a pivotal Phase 3 readout for its drug avexitide later this quarter, with results that could support approval to treat severe blood sugar drops after weight-loss
Clinical dietitian Cole Hanson argues the One Big Beautiful Bill's simultaneous $863 billion Medicaid cut and $295 billion SNAP cut are deepening the bidirectional crisis of hunger and mental illness,
CMS proposed 2027 hospital outpatient and physician fee rules that would create a more consistent payment framework for clinical software and AI tools, factoring in patient outcomes rather than just p
An opinion column by LSU professor Steve Midway argues that animal venoms have produced a string of blockbuster pharmaceuticals — from snake-derived ACE inhibitors to Gila monster-derived GLP-1 drugs
Johns Hopkins researchers identified claudin-4 as the receptor that the BFT toxin from Bacteroides fragilis uses to attack colon cells, ending a 15-year search and pointing to a decoy-based therapy th
The first person has received a pioneering gene therapy aimed at reversing cellular ageing, in a trial focused initially on restoring vision by rejuvenating retinal cells.
Cytiva experts say AI and big data are flooding drug discovery pipelines with high-potential candidates faster than manufacturing — especially purification — can safely handle at commercial scale.
Neko Health, the body-scanning startup co-founded by Spotify CEO Daniel Ek, raised $700 million in a Series C led by Lightspeed Venture Partners and O.G. Venture Partners to fund its first U.S. clinic
Research presented at the Alzheimer's Association International Conference in London suggests blood-based biomarker tests are advancing toward primary care, potentially making Alzheimer's diagnosis mo
A Mayo Clinic whistleblower has filed a lawsuit alleging she was forced out of her job after raising concerns about unethical practices in the health system's deployment of AI and related technology.
Curated health stories, every morning. Free.
No spam. Unsubscribe anytime.